Revenio Group Oyj Company Description

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.

The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel.

It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images.

In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities.

Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

Revenio Group Oyj

Country	Finland
Founded	2001
Industry	Computer Integrated Systems Design
Employees	241
CEO	Jouni Toijala

Contact Details

Address: Äyritie 22 Vantaa, 01510 Finland
Phone	358 9 8775 1150
Website	reveniogroup.fi

Stock Details

Ticker Symbol	R0V
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	7373

Key Executives

Name	Position
Jouni Toijala	Chief Executive Officer
Robin Pulkkinen	Chief Financial Officer
Ari Isomäki	Chief Operating Officer